Actavis Group, an international generic pharmaceuticals
company, today announced that it has received approval from the FDA to market Pantoprazole
Sodium Delayed-Release Tablets, USP. Distribution of the product will commence
shortly.
Pantoprazole Sodium Delayed-Release Tablets 20mg and 40mg,
the generic equivalent of Protonix 20mg and 40mg by Pfizer, had US sales of approximately
$1.6 billion for the 12 months ending December 31, 2010, according to IMS
Health.
